GxP Quality Systems & Audit Readiness Consulting
Independent QMS gap assessment, FDA inspection readiness and audit preparation for pharmaceutical, biotech, medical device and other regulated organizations.
When This Matters
Useful before FDA, notified-body, customer or internal audits; before enterprise diligence; when a QMS has grown faster than the organization; or when procedures exist but execution and evidence do not consistently demonstrate control.
What We Evaluate
Governance, document control, training, CAPA, deviations and investigations, change control, supplier quality, complaints, internal audits, risk management, management review, data integrity and the traceability of evidence between procedures and actual execution.
What You Receive
A prioritized gap assessment separating material compliance risk from lower-value cleanup, with recommended remediation actions, owners and sequencing so readiness work is focused where it matters.
Senior-Led Audit and Inspection Readiness
QA PharmaPro brings more than two decades of hands-on Quality experience across audits, CAPA, deviations, investigations, change control, validation, supplier quality and regulated manufacturing. The objective is not a generic checklist: it is to test whether procedures, execution and records form a defensible evidence trail.
When findings already exist, our CAPA, investigation and remediation support connects readiness work with sustainable corrective action.